D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
LENZ holding history
LENZ Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LENZ overviewAll 13F holders of LENZFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −7,447−100.0% | Sold out | Holders |
| Q4 2024 | 7,447 | $215.0K | <0.1% | +7,447 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −47,426−100.0% | Sold out | Holders |
| Q3 2023 | 47,426 | $117.6K | <0.1% | +7,542+18.9% | Added | Holders |
| Q2 2023 | 39,884 | $103.7K | <0.1% | +9,500+31.3% | Added | Holders |
| Q1 2023 | 30,384 | $74.4K | <0.1% | +100+0.3% | Added | Holders |
| Q4 2022 | 30,284 | $100.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 30,284 | $96.0K | <0.1% | −16,765−35.6% | Reduced | Holders |
| Q2 2022 | 47,049 | $129.0K | <0.1% | +47,049 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −53,472−100.0% | Sold out | Holders |
| Q3 2021 | 53,472 | $876.0K | <0.1% | +53,472 | New | Holders |